Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

4 treatments under study, led by 3d Transcranial Ultrasound Brain Imaging

Research Leaders

9 sponsors active, led by The Geneva Foundation

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown2
Terminated1
Completed1
Active Not Recruiting1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • 3d Transcranial Ultrasound Brain Imaging1
  • Evacuation Of Traumatic Acute Subdural Hematoma1
  • Handheld Brain Hematoma Detector1
  • Infrascanner 20001

Active Sponsors

  • The Geneva Foundation1
  • Assiut University1
  • Centre Hospitalier Universitaire de Saint Etienne1
  • U.S. Army Medical Research and Development Command1
  • InfraScan, Inc.1

Top Investigators

Related Conditions

  • Traumatic Brain Injury3
  • Intracranial Hemorrhages2
  • Head Trauma1
  • 3d Sonography1
  • Intracerebral Hemorrhage Traumatic1

Activity Timeline